Charles River Laboratories (CRL) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Charles River Laboratories Revenue Highlights

Latest Revenue (Y)

$4.05B

Latest Revenue (Q)

$1.00B

Main Segment (Y)

Discovery and Safety Assessment

Main Geography (Y)

UNITED STATES

Charles River Laboratories Revenue by Period

Charles River Laboratories Revenue by Year

Date	Revenue	Change
2024-12-28	$4.05B	-1.92%
2023-12-30	$4.13B	3.86%
2022-12-31	$3.98B	12.31%
2021-12-25	$3.54B	21.08%
2020-12-26	$2.92B	11.55%
2019-12-28	$2.62B	15.67%
2018-12-29	$2.27B	21.99%
2017-12-30	$1.86B	10.48%
2016-12-31	$1.68B	23.34%
2015-12-26	$1.36B	5.06%
2014-12-27	$1.30B	11.34%
2013-12-28	$1.17B	3.19%
2012-12-29	$1.13B	-1.15%
2011-12-31	$1.14B	0.81%
2010-12-25	$1.13B	-5.75%
2009-12-26	$1.20B	-10.49%
2008-12-27	$1.34B	9.17%
2007-12-29	$1.23B	16.27%
2006-12-30	$1.06B	-5.69%
2005-12-31	$1.12B	46.33%
2004-12-25	$766.92M	24.96%
2003-12-27	$613.72M	10.65%
2002-12-28	$554.63M	19.11%
2001-12-29	$465.63M	51.88%
2000-12-31	$306.58M	39.82%
1999-12-25	$219.28M	13.44%
1998-12-31	$193.30M	-

Charles River Laboratories generated $4.05B in revenue during NA 2024, up -1.92% compared to the previous quarter, and up 154.51% compared to the same period a year ago.

Charles River Laboratories Revenue by Quarter

Date	Revenue	Change
2024-12-28	$1.00B	-0.71%
2024-09-28	$1.01B	-1.59%
2024-06-29	$1.03B	1.44%
2024-03-30	$1.01B	-0.19%
2023-12-30	$1.01B	-1.28%
2023-09-30	$1.03B	-3.14%
2023-07-01	$1.06B	2.97%
2023-04-01	$1.03B	-6.41%
2022-12-31	$1.10B	11.19%
2022-09-24	$989.16M	1.65%
2022-06-25	$973.13M	6.48%
2022-03-26	$913.93M	0.98%
2021-12-25	$905.05M	1.02%
2021-09-25	$895.94M	-2.04%
2021-06-26	$914.61M	10.92%
2021-03-27	$824.57M	4.24%
2020-12-26	$790.99M	6.42%
2020-09-26	$743.30M	8.90%
2020-06-27	$682.58M	-3.46%
2020-03-28	$707.06M	2.30%
2019-12-28	$691.14M	3.47%
2019-09-28	$667.95M	1.58%
2019-06-29	$657.57M	8.77%
2019-03-30	$604.57M	0.51%
2018-12-29	$601.53M	2.77%
2018-09-29	$585.29M	-0.00%
2018-06-30	$585.30M	18.49%
2018-03-31	$493.97M	3.24%
2017-12-30	$478.48M	3.07%
2017-09-30	$464.23M	-1.04%
2017-07-01	$469.13M	5.24%
2017-04-01	$445.76M	-4.50%
2016-12-31	$466.79M	9.65%
2016-09-24	$425.72M	-1.92%
2016-06-25	$434.06M	22.31%
2016-03-26	$354.87M	0.29%
2015-12-26	$353.85M	1.25%
2015-09-26	$349.46M	2.91%
2015-06-27	$339.57M	5.98%
2015-03-28	$320.41M	-2.77%
2014-12-27	$329.55M	0.60%
2014-09-27	$327.57M	-3.99%
2014-06-28	$341.18M	13.97%
2014-03-29	$299.37M	3.51%
2013-12-28	$289.23M	-0.99%
2013-09-28	$292.13M	-0.27%
2013-06-29	$292.93M	0.58%
2013-03-30	$291.24M	3.96%
2012-12-29	$280.14M	0.52%
2012-09-29	$278.69M	-2.12%
2012-06-30	$284.72M	-0.44%
2012-03-31	$285.98M	-1.71%
2011-12-31	$290.96M	4.82%
2011-09-24	$277.58M	-3.71%
2011-06-25	$288.26M	0.85%
2011-03-26	$285.84M	6.70%
2010-12-25	$267.89M	-2.97%
2010-09-25	$276.08M	-5.49%
2010-06-26	$292.10M	-1.76%
2010-03-27	$297.35M	0.66%
2009-12-26	$295.38M	-0.71%
2009-09-26	$297.49M	-3.46%
2009-06-27	$308.16M	2.20%
2009-03-28	$301.53M	-3.19%
2008-12-27	$311.45M	-8.99%
2008-09-27	$342.23M	-2.81%
2008-06-28	$352.13M	4.28%
2008-03-29	$337.69M	6.18%
2007-12-29	$318.03M	-

Charles River Laboratories generated $1.00B in revenue during Q4 2024, up -0.71% compared to the previous quarter, and up 97.66% compared to the same period a year ago.

Charles River Laboratories Revenue Breakdown

Charles River Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Discovery and Safety Assessment	$2.45B	$2.62B	-	-	-
Manufacturing Support	$769.33M	$721.44M	-	-	-
Research Models and Services	$829.38M	$792.34M	-	-	-
Service	-	$3.44B	$3.22B	$2.76B	$2.30B
Product	-	$689.39M	$759.16M	$784.58M	$627.78M

Charles River Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 24: Discovery and Safety Assessment (60.53%), Research Models and Services (20.48%), and Manufacturing Support (19.00%).

Quarterly Revenue by Product

Product/Service	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Apr 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Discovery and Safety Assessment	$592.61M	$1.23B	$615.06M	$605.45M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Manufacturing Support	$178.49M	$387.25M	$196.88M	$185.20M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product	-	-	-	$194.70M	$175.47M	$156.86M	$185.05M	$172.01M	$199.15M	$176.26M	$190.30M	$193.44M	$195.23M	$192.08M	$199.29M	$197.99M	$172.76M	$162.53M	$132.02M	$160.47M
Service	-	-	-	$816.86M	$838.00M	$869.76M	$874.89M	$857.37M	$900.70M	$812.89M	$782.83M	$720.49M	$709.82M	$703.86M	$715.32M	$626.58M	$618.23M	$580.77M	$550.56M	$546.59M

Charles River Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Discovery and Safety Assessment (76.85%), and Manufacturing Support (23.15%).

Charles River Laboratories Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Asia Pacific	$196.95M	$200.83M	$192.84M	$222.90M	-
CANADA	$482.09M	$487.31M	$398.98M	$339.10M	$306.26M
Europe	$1.08B	$1.08B	$1.03B	$1.04B	$829.31M
UNITED STATES	$2.24B	$2.35B	$2.34B	$1.93B	$1.63B
Other	-	$16.85M	$9.96M	$7.29M	$6.13M
JAPAN	-	-	-	-	$155.09M

Charles River Laboratories's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (56.04%), Europe (26.97%), CANADA (12.06%), and Asia Pacific (4.93%).

Quarterly Revenue by Country

Country	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Apr 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
CANADA	$125.35M	$244.60M	$127.09M	$110.40M	$130.03M	$129.02M	$117.65M	$110.61M	$118.44M	$101.60M	$93.69M	$85.25M	$86.17M	$85.25M	$90.56M	$77.11M	$79.09M	$79.00M	$71.54M	$76.63M
Asia Pacific	$41.94M	$106.17M	$45.01M	$45.77M	$57.92M	$40.23M	$59.86M	$42.81M	$53.85M	$43.80M	$46.24M	$48.95M	$51.72M	$56.61M	$55.13M	$59.45M	$41.55M	$35.97M	$31.83M	-
Europe	$263.25M	$534.70M	$267.12M	$276.32M	$271.47M	$264.79M	$272.98M	$267.70M	$271.53M	$245.93M	$263.58M	$251.09M	$264.87M	$258.35M	$275.71M	$237.53M	$233.92M	$214.19M	$190.94M	$190.26M
UNITED STATES	$536.96M	$1.12B	$559.28M	$562.32M	$544.95M	$590.32M	$606.77M	$605.44M	$653.43M	$595.26M	$566.92M	$526.55M	$500.74M	$493.56M	$491.62M	$448.48M	$430.54M	$406.98M	$382.92M	$406.71M
Other	-	-	-	$16.75M	$9.10M	$2.26M	$2.67M	$2.81M	$2.60M	$2.56M	$2.70M	$2.10M	$1.55M	$2.16M	$1.58M	$2.00M	$1.70M	$1.58M	$1.22M	$1.62M

Charles River Laboratories's latest quarterly revenue breakdown by geography, as of Mar 25: UNITED STATES (55.50%), Europe (27.21%), CANADA (12.96%), and Asia Pacific (4.34%).

Charles River Laboratories Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
IQV	IQVIA	$15.40B	$3.83B
LH	Laboratory Corporation of America	$12.16B	$3.35B
ICLR	ICON Public	$8.12B	$2.09B
A	Agilent	$6.83B	$1.68B
ILMN	Illumina	$4.37B	$1.10B
CRL	Charles River Laboratories	$4.05B	$1.00B
IDXX	IDEXX Laboratories	$3.90B	$998.43M
MTD	Mettler-Toledo	$3.87B	$883.74M
WAT	Waters	$2.96B	$661.71M
RVTY	Revvity	$2.76B	$664.76M
MEDP	Medpace	$2.11B	$558.57M
GH	Guardant Health	$739.02M	$203.47M
CDNA	CareDx	$333.79M	$84.69M

CRL Revenue FAQ

What is Charles River Laboratories’s yearly revenue?

Charles River Laboratories's yearly revenue for 2024 was $4.05B, representing a decrease of -1.92% compared to 2023. The company's yearly revenue for 2023 was $4.13B, representing an increase of 3.86% compared to 2022. CRL's yearly revenue for 2022 was $3.98B, representing an increase of 12.31% compared to 2021.

What is Charles River Laboratories’s quarterly revenue?

Charles River Laboratories's quarterly revenue for Q4 2024 was $1B, a -0.71% decrease from the previous quarter (Q3 2024), and a -1.08% decrease year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $1.01B, a -1.59% decrease from the previous quarter (Q2 2024), and a -1.64% decrease year-over-year (Q3 2023). CRL's quarterly revenue for Q2 2024 was $1.03B, a 1.44% increase from the previous quarter (Q1 2024), and a -3.19% decrease year-over-year (Q2 2023).

What is Charles River Laboratories’s revenue growth rate?

Charles River Laboratories's revenue growth rate for the last 3 years (2022-2024) was 1.86%, and for the last 5 years (2020-2024) was 38.51%.

What are Charles River Laboratories’s revenue streams?

Charles River Laboratories's revenue streams in c 24 are Discovery and Safety Assessment, Manufacturing Support, and Research Models and Services. Discovery and Safety Assessment generated $2.45B in revenue, accounting 60.53% of the company's total revenue, down -6.28% year-over-year. Manufacturing Support generated $769.33M in revenue, accounting 19.00% of the company's total revenue, up 6.64% year-over-year. Research Models and Services generated $829.38M in revenue, accounting 20.48% of the company's total revenue, up 4.67% year-over-year.

What is Charles River Laboratories’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Charles River Laboratories was Discovery and Safety Assessment. This segment made a revenue of $2.45B, representing 60.53% of the company's total revenue.